Leukocyte Filter Enhances Neutrophil Activation during Combined Aortic Valve and Coronary Artery Bypass Surgery
DOI:
https://doi.org/10.1532/HSF98.20061008Abstract
Objective. Cardiopulmonary bypass-induced systemic inflammatory reaction involving the expression of neutrophil surface adhesion molecules is the main mechanism leading to myocardial ischemia-reperfusion injury as well as multiorgan dysfunction. Patients undergoing prolonged cardiopulmonary bypass are especially at risk in this regard. The aim of this prospective, randomized study was to evaluate the impact of continuous leukocyte filtration on the perioperative expression of neutrophil adhesion molecules along with the markers of systemic inflammation during combined coronary artery revascularization and aortic valve surgery due to aortic stenosis.
Patient and Methods. Twenty patients scheduled for combined coronary artery revascularization and aortic valve surgery due to aortic stenosis were randomized to undergo cardiopulmonary bypass with or without a leukocyte filter (LeukoGuard LG6). The expression of neutrophil adhesion molecules and proinflammatory cytokine response were measured.
Results. The use of the leukocyte filter significantly increased neutrophil CD11b expression (Pg = .003) compared to the control group, which was followed by a faster rise in interleukin-6 levels 5 minutes (median, 125 versus 34 pg/mL) and 2 hours after cardiopulmonary bypass (median, 158 versus 92 pg/mL, Pt × g < .001), respectively. No marked differences in terms of levels of CD11a, CD62L, cardiac troponin-I, or oxyhemodynamics were observed.
Conclusions. The observed increased neutrophil activation and enhanced inflammatory response do not support the use of continuous leukofiltration in patients undergoing prolonged cardiopulmonary bypass.
References
Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. 1996. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 112:494-500.nIlmakunnas M, Pesonen EJ, Ahonen J, et al. 2005. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thorac Cardiovasc Surg 129:851-9.nLust RM, Bode AP, Yang L, Hodges W, Chitwood WR Jr. 1996. In-line leukocyte filtration during bypass. Clinical results from a randomized prospective trial. ASAIO J 42:M819-22.nLeal-Noval SR, Amaya R, Herruzo A, et al. 2005. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Ann Thorac Surg 80:1394-400.nMihaljevic T, Tonz M, von Segesser LK, et al. 1995. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study. J Thorac Cardiovasc Surg 109:1138-45.nOlivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. 2003. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Perfusion 18(suppl 1):23-31.nScholz M, Simon A, Matheis G, et al. 2002. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res 51:363-8.nSutton SW, Patel AN, Chase VA, et al. 2005. Clinical benefits of continuous leukocyte filtration during cardiopulmonary bypass in patients undergoing valvular repair of replacement. Perfusion 20:21-9.nEfstathiou A, Vlachveis M, Tsonis G, Asteri T, Psarakis A, Fessatidis IT. 2003. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome? J Cardiovasc Surg 44:197-204.nel Habbal MH, Smith LJ, Elliott MJ, et al. 1997. Cardiopulmonary bypass tubes and prime solutions stimulate neutrophil adhesion molecules. Cardiovasc Res 33:209-15.nFabbri A, Manfredi J, Piccin C, et al. 2001. Systemic leukocyte filtration during cardiopulmonary bypass. Perfusion 16(suppl):11-8.nFriehs I, del Nido PJ. 2003. Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg 75:S678-84.nGillinov AM, Redmond JM, Winkelstein JA, et al. 1994. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 57:345-52.nGillinov AM, Bator JM, Zehr KJ, et al. 1993. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 56:847-53.nSahlman A, Ahonen J, Salo JA, Ramo OJ. 2001. No impact of a leukocyte arterial line filter on patient recovery after cardiopulmonary bypass. Acta Anaesthesiol Scand 45:558-63.nPatel AN, Sutton SW, Livingston S, et al. 2003. Clinical benefits of leukocyte filtration during valve surgery. Am J Surg 186:639-49.nRimpiläinen J, Pokela M, Kiviluoma K, et al. 2000. Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: a study in a chronic porcine model. J Thorac Cardiovasc Surg 120:1131-41.nRinder CS, Fontes M, Mathew JP, et al. 2003. Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. Ann Thorac Surg 75:899-905.nRoth M, Kraus B, Scheffold T, Reuthebuch O, Klovekorn WP, Bauer EP. 2000. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg 120:642-50.nSalamonsen RF, Anderson J, Anderson M, et al. 2005. Total leukocyte control for elective coronary bypass surgery does not improve short-term outcome. Ann Thorac Surg 79:2032-8.nKoskenkari J, Rimpiläinen J, Biancari F, et al. 2005. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery. Scand Cardiovasc J 39:358-68.nKoskenkari JK, Kaukoranta PK, Kiviluoma KT, et al. 2005. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery. Ann Thorac Surg 80:511-7.nEdwards FH, Peterson ED, Coombs LP. 2001. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37:885-92.nKaraiskos TE, Palatianos GM, Triantafillou CD, et al. 2004. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 78:1339-44.nKirklin JK, Westaby S, Blackstone EH, et al. 1983. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86:845-57.nBaksaas ST, Flom-Halvorsen HI, Ovrum E, et al. 1999. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion 14;107-17.nChen YF, Tsai WC, Lin CC, et al. 2002. Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings. J Thorac Cardiovasc Surg 123:218-24.nde Vries AJ, Gu YJ, Post WJ. 2003. Leukocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion 18:31-8.nEdmunds LH Jr. 1998. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 66(suppl 5):S12-6; discussion S25-8.n
